CD163 as a Predictive Prognostic Protein in Alzheimer's Disease
The biomarkers analyzed describe the dementia group more accurately; therefore, the positive correlation found between CD163 CSF levels and total-tau, Aβ<sub>42</sub>, and pTau181 reinforces the role of CD163 as a potential indicator of advanced inflammatory and neurodegenerative processes. These results open new perspectives on the role of CD163 in AD.
Authors
- João Batista Teixeira da Rocha (ORCID: https://orcid.org/0000-0003-3829-0595)
- Guilherme Schmitt Rieder
- Christian Limberger (ORCID: https://orcid.org/0000-0002-5160-3886)
- Marco Antônio De Bastiani (ORCID: https://orcid.org/0000-0003-3924-5278)
- Débora Guerini de Souza (ORCID: https://orcid.org/0000-0003-2982-4989)
- Gabriela Mantovani Baldasso
- Diogo O. Souza
- Eduardo R. Zimmer
Institutions
- Universidade Federal do Rio Grande do Sul (BR)
- Instituto do Cérebro (BR)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70855_106218
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00